Elixirs of death. International organizations are working towards a global solution to address the problem of falsified and substandard medicines, but progress has stagnated.
作者信息
Weigmann Katrin
出版信息
EMBO Rep. 2013 Jul;14(7):597-600. doi: 10.1038/embor.2013.82. Epub 2013 Jun 14.
Abstract
摘要
相似文献
1
Elixirs of death. International organizations are working towards a global solution to address the problem of falsified and substandard medicines, but progress has stagnated.致命的长生不老药。国际组织正在努力寻求全球解决方案以应对假药和劣药问题，但进展陷入了停滞。
EMBO Rep. 2013 Jul;14(7):597-600. doi: 10.1038/embor.2013.82. Epub 2013 Jun 14.
2
How to achieve international action on falsified and substandard medicines.如何在假药和劣药问题上采取国际行动。
BMJ. 2012 Nov 13;345:e7381. doi: 10.1136/bmj.e7381.
3
[Fake drugs, what are we talking about? Counterfeit drugs, informal market, quality of pharmaceutical… Thought from an anthropological study led in Benin].[假药，我们在谈论什么？假冒药品、非正式市场、药品质量……来自在贝宁开展的一项人类学研究的思考]
Bull Soc Pathol Exot. 2014 May;107(2):121-6. doi: 10.1007/s13149-014-0354-9. Epub 2014 Mar 17.
4
When falsified medicines enter the supply chain: description of an incident in Kenya and lessons learned for rapid response.当假药进入供应链时：肯尼亚事件描述及快速应对的经验教训。
J Public Health Policy. 2013 Jan;34(1):22-30. doi: 10.1057/jphp.2012.53. Epub 2012 Nov 22.
5
Impact of substandard and falsified antimalarials in Zambia: application of the SAFARI model.赞比亚不合格和假冒抗疟药物的影响：SAFARI 模型的应用。
BMC Public Health. 2020 Jul 9;20(1):1083. doi: 10.1186/s12889-020-08852-w.
6
Regulatory framework for access to safe, effective quality medicines.获取安全、有效、高质量药品的监管框架。
Antivir Ther. 2014;19 Suppl 3:69-77. doi: 10.3851/IMP2902. Epub 2014 Oct 13.
7
Counterfeit medicines. Bitter pills.假药。苦果。
BMJ. 2007 Dec 1;335(7630):1120-1. doi: 10.1136/bmj.39412.431655.AD.
8
European union has the falsified medicines directive.欧盟有《假药指令》。
BMJ. 2012 Dec 20;345:e8356. doi: 10.1136/bmj.e8356.
9
Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.非洲和亚洲的地方组织使用低成本的全球公共卫生实验室微量实验室对假药和劣药进行监测。
PLoS One. 2017 Sep 6;12(9):e0184165. doi: 10.1371/journal.pone.0184165. eCollection 2017.
10
Commentary: Substandard medicines are the priority for neglected tropical diseases.评论：不合格药品是被忽视热带病防治工作的重点。
BMJ. 2012 Nov 14;345:e7518. doi: 10.1136/bmj.e7518.
引用本文的文献
1
Quality of Artemisinin-based Combination Therapy for malaria found in Ghanaian markets and public health implications of their use.加纳市场上青蒿素联合疗法治疗疟疾的质量及其使用对公共卫生的影响。
BMC Pharmacol Toxicol. 2016 Oct 28;17(1):48. doi: 10.1186/s40360-016-0089-2.
2
Counterfeit medicines in Peru: a retrospective review (1997-2014).秘鲁的假冒药品：回顾性研究（1997 - 2014年）
BMJ Open. 2016 Apr 4;6(4):e010387. doi: 10.1136/bmjopen-2015-010387.
本文引用的文献
1
Potential risks of pharmacy compounding.药剂配制的潜在风险。
Drugs R D. 2013 Mar;13(1):1-8. doi: 10.1007/s40268-013-0005-9.
2
How to achieve international action on falsified and substandard medicines.如何在假药和劣药问题上采取国际行动。
BMJ. 2012 Nov 13;345:e7381. doi: 10.1136/bmj.e7381.
3
Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa.东南亚和撒哈拉以南非洲劣质的抗疟药物。
Lancet Infect Dis. 2012 Jun;12(6):488-96. doi: 10.1016/S1473-3099(12)70064-6.
4
Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study.泰国西部边境地区青蒿素耐药疟疾的出现：一项纵向研究。
Lancet. 2012 May 26;379(9830):1960-6. doi: 10.1016/S0140-6736(12)60484-X. Epub 2012 Apr 5.
5
EU implicated in controversial counterfeiting bill.
Lancet. 2010 Apr 17;375(9723):1335. doi: 10.1016/s0140-6736(10)60560-0.
6
Impact of poor-quality medicines in the 'developing' world.劣质药品对“发展中”世界的影响。
Trends Pharmacol Sci. 2010 Mar;31(3):99-101. doi: 10.1016/j.tips.2009.11.005. Epub 2010 Feb 1.
7
Influence of tropical climate conditions on the quality of antihypertensive drugs from Rwandan pharmacies.热带气候条件对卢旺达药店抗高血压药物质量的影响。
Am J Trop Med Hyg. 2009 Nov;81(5):776-81. doi: 10.4269/ajtmh.2009.09-0109.
8
Outbreak of acute renal failure in Panama in 2006: a case-control study.2006年巴拿马急性肾衰竭疫情：一项病例对照研究。
Bull World Health Organ. 2008 Oct;86(10):749-56. doi: 10.2471/blt.07.049965.
9
Quality of amoxicillin formulations in some Arab countries.一些阿拉伯国家阿莫西林制剂的质量。
J Clin Pharm Ther. 2008 Aug;33(4):375-9. doi: 10.1111/j.1365-2710.2008.00926.x.
10
The global threat of counterfeit drugs: why industry and governments must communicate the dangers.假药的全球威胁：为何制药行业与政府必须传达其危害
PLoS Med. 2005 Apr;2(4):e100. doi: 10.1371/journal.pmed.0020100. Epub 2005 Mar 14.
Zotero 插件